TrialMolecular psychiatry2020

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.

Maurizio Fava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.